Negative Pressure Wound Therapy Market Analysis by SWOT, Investment, Future Growth and Major Key Players 2020 to 2027

 

Overview:

The global negative pressure wound therapy market is expected to exhibit a CAGR of 6.7% over the forecast period from 2018 to 2023, according to a new report from Market Research Future (MRFR). The report profiles the global negative pressure wound therapy market’s historical statistics in order to provide reliable insights and predictions into the global negative pressure wound therapy market’s likely growth trajectory over the forecast period. Key players and leading segments in the global negative pressure wound therapy market are also profiled in the report to provide readers with an accurate picture of the market’s inner dynamics.

Negative pressure wound therapy is carried out by covering a wound in a special sealed dressing and exposing it to a vacuum, which draws out pus and other such residue and helps clarify the wound by improving blood circulation in the region. The global negative pressure wound therapy market has mainly grown in the 1990s and 2000s following the development of the method and gradual growth in the awareness about its effectiveness. The growing demand for wound healing systems that promote quick wound healing is expected to be a major driver for the global negative pressure wound therapy market over the forecast period. The clean and noninvasive nature of negative pressure wound therapy is also likely to be a major market driver over the forecast period.

Segmentation:

The advanced negative pressure wound therapy market has been segmented on the basis of product type, wound type, end user, and region.

On the basis of product type, the negative pressure wound therapy market has been segmented into conventional negative pressure wound therapy devices, single-use negative pressure wound therapy devices, and accessories. The conventional segment accounted for the largest share of the global market in 2017 due to its effectiveness in handling large volumes of exudates.

By wound type, the global negative pressure wound therapy market is segmented into surgical and traumatic wounds, ulcers, and burns. The ulcers segment has been further subclassified as venous ulcers, foot ulcers, pressure ulcers, and others.

By end use, the global negative pressure wound therapy market is segmented into hospitals, home care settings, and others. Hospitals are likely to remain the leading end user in the global negative pressure wound therapy market over the forecast period due to their prominent role in wound care and the easy availability of advanced negative pressure wound therapy systems in hospitals.

Regional Analysis:

The global negative pressure wound therapy market is segmented into the Americas, Europe, the Middle East and Africa, and Asia Pacific. The Americas segment is expected to dominate the global negative pressure wound therapy market over the forecast period due to the growing demand for wound therapy in the region and the increasing advancement of the healthcare sector, which is facilitating easy access to advanced solutions such as negative pressure wound therapy across the region. According to the National Diabetes Statistics Report, the U.S. housed more than 30.3 million diabetics in 2017. This is likely to be a key driver for the negative pressure wound therapy market in the region over the forecast period.

Europe is also likely to retain a dominant share in the global negative pressure wound therapy market over the forecast period due to the technological advancement of the healthcare sector in the region. Growing prevalence of diabetes could also emerge as a key driver for the negative pressure wound therapy market in Europe over the forecast period.

Negative Pressure Wound Therapy Market Players

·         Acelity L.P. Inc.

·         ConvaTec Group plc

·         Smith & Nephew

·         Talley Group

·         Genadyne

·         Molnlycke Health Care AB

·         Medela

·         Lohmann & Rauscher International GmbH & Co. K

among others are some key companies in the global Negative Pressure Wound Therapy that are listed by MRFR for market research.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Comments

Post a Comment

Popular posts from this blog

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth Opportunities, Demand and Forecasts, 2020-2027

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device market . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Segmentation The global cardiac monitoring and  card...
Read more

Cancer Biological Therapy Market Demand, Business Strategies, Current Trends And Efficient Techniques, Forecast 2030

  Market Highlights Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. These various types of biological therapies, which are most of the times stated to biological modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies. Cancer Biological therapy market  treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such c...
Read more

Medical Imaging Software Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

  Medical Imaging Software Market Highlights Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals m...
Read more